Diabetes in cystic fibrosis

Andersen D.H. Cystic fibrosis of the pancreas and its relation to celiac disease. Am J Dis Child 1938; 56: 344–99.

Shwachman H. , Leubner H. , Catzel P. Mucoviscidosis. Adv Pediatr 1955; 7: 249–323.

Hodson M.E. Diabetes mellitus and cystic fibrosis. Baillière's Clin Endocrinol Metab 1992; 6: 797–805.

Dodge J.A. , Morrison G. Diabetes mellitus in cystic fibrosis: a review. J R Soc Med 1992; 85(Suppl. 19): 25–8.

FitzSimmons S.C. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122: 1–9.

Lanng S. , Hansen A. , Thorsteinsson B. , Nerup J. , Koch C. Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ 1995; 311: 655–9.

Moran A. Highlights of the February 1998 Consensus Conference on CFRD. Pediatr Pulmonol 1998; 26(Suppl. 17): 104.

Rodman H.M. , Doershuk C.F. , Roland J.M. The interaction of 2 diseases: Diabetes mellitus and cystic fibrosis. Medicine 1986; 65: 389–97.

Finkelstein S.M. , Wielinski C.L. , Elliott G.R. Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988; 112: 373–7.

Reisman J. , Corey M. , Canny G. , Levison H. Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics 1990; 86: 374–7.

Rosenecker J. , Eichler I. , Kuhn L. , Harms H.K. , von der Hardt H. Genetic determination of diabetes mellitus in patients with cystic fibrosis. J Pediatr 1995; 127: 441–3.

Lanng S. , Thorsteinsson B. , Lund-Andersen C. , Nerup J. , Schiotz P.O. , Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Pediatr 1994; 83: 72–7.

Hamdi I. , Payne S.J. , Barton D.E. Genotype analysis in cystic fibrosis in relation to the occurrence of diabetes mellitus. Clin Genet 1993; 43: 186–9.

Kerem E. , Corey M. , Kerem B.S. The relationship between genotype and phenotype in cystic fibrosis: analysis of the most common mutation (delta F508). N Engl J Med 1990; 323: 1517–22.

Kristidis P. , Bozon D. , Corey M. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 1992; 50: 1178–84.

Geffner M.E. , Lippe B.M. , Kaplan S.A. Carbohydrate tolerance in cystic fibrosis is closely linked to pancreatic exocrine function. Pediatr Res 1984; 18: 1107–11.

Moran A. , Diem P. , Klein D.J. , Levitt M.D. , Robertson R.P. Pancreatic endocrine function in cystic fibrosis. J Pediatr 1991; 118: 715–23.

De Luca F. , Arrigo T. , Conti Nibali S. Insulin secretion, glycosylated haemoglobin and islet cell antibodies in cystic fibrosis children and adolescents with different degrees of glucose tolerance. Horm Metab Res 1991; 23: 495–8.

Lanng S. , Thorsteinsson B. , Pociot F. Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Pediatr 1993; 82: 150–4.

Cucinotta D. , Conti Nabali S. , Arrigo T. Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance. Horm Res 1990; 34: 33–8.

Geffer M.E. , Lippe B.M. , McLaren N.K. , Riley W.J. Role of insulinopenic and carbohydrate derangement in patients with cystic fibrosis. J Pediatr 1988; 122: 419–21.

Carrington M. , Krueger L.J. , Holsclaw D.S. Jr. , Iannuzzi M.C. , Dean M. , Mann D. Cystic fibrosis related diabetes is associated with HLA DQB1 alleles encoding Asp-57 sup(-) molecules. J Clin Immunol 1994; 14: 353–8.

Jackson A.D.M. The natural history of cystic fibrosis. In: Goodfellow P. , ed. Cystic Fibrosis. Oxford: Oxford University Press, 1989: 1–11.

Mearns M.B. Cystic fibrosis: The first 50 years. A review of the clinical problems and their management. In: Dodge J.A. , Brock D.J.H. , Widdicombe J.H. , eds. Cystic Fibrosis: Current Topics. Chichester: John Wiley & Sons, 1993: 217–50.

Couce M. , O'Brien T.D. , Moran A. , Roche P.C. , Butler P.C. Diabetes mellitus in cystic fibrosis is characterised by islet amyloidosis. J Clin Endocrinol Metab 1996; 81: 1267–72.

Moran A. CF related diabetes mellitus. Pediatr Pulmonol 1995; Suppl. 12: 95–6.

Allen H.F. , Klingensmith G.J. , Gay E.C. , Hamman R.F. Identification and treatment of cystic fibrosis-related diabetes. Diabetes Care 1998; 21: 943–8.

Stutchfield P.R. , O'Hallovan S. , Teale J.D. , Isherwood D. , Smith C.S. , Heaf D. Glycosylated haemoglobin and glucose intolerance in cystic fibrosis. Arch Dis Child 1987; 62: 805–10.

Robert J.J. , Grasset E. , de Montalembert M. , Chevenne D. , Deschamps I. , Boitard C. [Research of factors for glucose intolerance in mucoviscidosis.] Archives Françaises de Pédiatrie 1992; 49: 17–22.

Arrigo T. , Cucinotta D. , Conti Nibali S. Longitudinal evaluation of glucose tolerance and insulin secretion in non-diabetic children and adolescents with cystic fibrosis: results of a two year follow-up. Acta Pediatr 1993; 82: 249–53.

Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–97.

WHO. Diabetes Mellitus. Technical report series 727. WHO: Geneva, 1985.

Wareham N.J. , O'Rahilly S. The changing classification and diagnosis of diabetes. BMJ 1998; 317: 359–60.

Yung B. , Kemp M. , Hooper J. , Hodson M.E. The diagnosis of cystic fibrosis related diabetes: A selective approach in performing oral glucose tolerance test based on a combination of clinical and biochemical criteria. Thorax 1999; 54: 40–3.

Yung B. , Kemp M. , Hooper J. , Hodson M.E. Random blood glucose alone in the diagnosis of cystic fibrosis-related diabetes. Lancet 1997; 349: 619.

Frase L.L. , Strickland A.D. , Kachel G.W. , Krejs G.J. Enhanced glucose absorption in the jejunum of patients with cystic fibrosis. Gastroenterology 1985; 88: 478–84.

Taylor C.J. Glucose intolerance in cystic fibrosis. Arch Dis Child 1989; 64: 759.

Holl R.W. , Buck C. , Cario H. Diagnosis of diabetes in cystic fibrosis and thalassemia major. Diabetes Care 1998; 21: 671–2.

Iannuci A. , Mukai K. , Johnson D. , Burke B. Endocrine pancreas in cystic fibrosis: an immunological study. Hum Pathol 1984; 153: 278–84.

Kopito L.E. , Schwachman H. The pancreas in cystic fibrosis: chemical composition and comparative morphology. Pediatr Res 1976; 10: 742–9.

Soejima K. , Landing B.H. Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: morphometric and immunocytological studies. Pediatric Pathology 1986; 6: 25–46.

Abdul-Karim F.W. , Dahms B.B. , Velasco M.E. , Rodman H.M. Islets of Langerhans in adolescents and adults with cystic fibrosis: a quantitative study. Arch Pathol Lab Med 1986; 110: 602–6.

Ahmad T. , Nelson R. , Taylor R. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis. Metabolism 1994; 43: 163–7.

Austin A. , Kalhan S.C. , Orenstein D. , Nixon P. , Arslanian S. Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J Clin Endocrinol Metab 1994; 79: 80–5.

Lanng S. , Thorsteinsson B. , Roder M. , Nerup J. , Koch C. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrinol 1994; 41: 217–23.

Moran A. , Pyzdrowski K. , Weinreb M.D. Insulin sensitivity in cystic fibrosis. Diabetes 1994; 43: 1020–6.

Cucinotta D. , De Luca F. , Gigante A. No changes in insulin sensitivity in cystic fibrosis patients with different degrees of glucose tolerance: an epidemiological and longitudinal study. Eur J Endocrinol 1994; 130: 253–8.

Hardin D.S. , LeBlanc A. , Lukenbaugh S. , Seilheimer D.K. Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr 1997; 130: 948–56.

Lanng S. Diabetes mellitus in cystic fibrosis. Eur J Gastroenterol Hepatol 1996; 8: 744–7.

Wareham N.J. , Philips D.I.W. , Byrne C.D. , Hales C.N. The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 1995; 12: 931.

Matthew D.R. , Hosker J.P. , Rudenski A.S. , Naylor B.A. , Treacher D.F. , Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–9.

Yung B. , Noormohamed F.H. , Kemp M. , Hooper J. , Lant A.F. , Hodson M.E. Pancreatic beta-cell dysfunction and insulin resistance in adult patients with cystic fibrosis. Pediatr Pulmonol 1998; 26(Suppl. 17): A568.

Lanng S. , Thorsteinsson B. , Nerup J. , Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Pediatr 1994; 83: 849–53.

Cucinotta D. , Arrigo T. , De Luca F. Metabolic and clinical events preceding diabetes mellitus onset in cystic fibrosis. Eur J Endocrinol 1996; 134: 731–6.

De Luca F. , Arrigo T. , Di Benedetto A. Four-year follow-up of glucose tolerance and beta-cell function in non-diabetic cystic fibrosis patients. Horm Res 1995; 44: 45–50.

Allen J.L. Progressive nephropathy in a patient with cystic fibrosis and diabetes. N Engl J Med 1985; 315: 764.

Dolan T.F. Microangiopathy in a young adult with cystic fibrosis and diabetes mellitus. N Engl J Med 1986; 314: 991.

Sullivan M.M. , Denning C.R. Diabetic microangiopathy in patients with cystic fibrosis. Pediatrics 1989; 84: 642–7.

Lanng S. , Thorsteinsson B. , Lund-Andersen C. , Nerup J. , Schiotz P.O. , Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Pediatr 1994; 83: 72–7.

Yung B. , Landers A. , Mathalone B. , Gyi K.M. , Hodson M.E. Diabetic retinopathy in adult patients with cystic fibrosis-related diabetes. Respir Med 1998; 92: 871–2.

Mogensen C.E. , Keane W.F. , Bennett P.H. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995; 346: 1080–4.

Schlesinger D.M. , Holsclaw D.S. , Fyfe B. Generalized atherosclerosis in an adult with CF and diabetes mellitus. Pediatr Pulmonol 1997; 23(Suppl. 14): 306.

Stewart C.J. , Wilson D.C. , Hanna A.K. Lipid metabolism is not abnormal in adults with cystic fibrosis related diabetes. Pediatr Pulmonol 1998; 26(Suppl. 17): A567.

Holl R.W. , Buck C. , Wolf A. , Thon A. , Debatin K.M. Arguments for sulfonylurea in the treatment of CF-related diabetes mellitus. Berlin: Proceedings 22nd European Cystic Fibrosis Conference, 1998: S4–3.

Bertele-Harms R.M. , Harms H.K. Long term experience with sulfonylurea treatment in cystic fibrosis related diabetes mellitus. Berlin: Proceedings 22nd European Cystic Fibrosis Conference, 1998: S4–4.

Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86.

UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.